http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070022243-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20070022243-A |
| titleOfInvention | Deferasirox dispersible tablet |
| abstract | The present invention provides 42 to 65% by weight of deferasirox 4- [3,5-bis (2-hydroxyphenyl)-[1,2,4] triazol-1-yl] benzoic acid as the active ingredient by weight of the total tablet. Or to a dispersible tablet comprising a pharmaceutically acceptable salt thereof.n n n Deferasirox, 4- [3,5-bis (2-hydroxyphenyl)-[1,2,4] triazol-1-yl] benzoic acid, dispersible tablets, chelation therapy |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150126900-A |
| priorityDate | 2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.